Discover how custom data, advanced methods, and next-generation technologies like AI and MCPs are reshaping target discovery.
Are you exploring drug targets and looking to make the most of Open Targets’ growing ecosystem? Watch this webinar to discover how custom data, advanced methods, and next-generation technologies like AI and MCPs are reshaping target discovery.
Translational scientists and drug discovery researchers
Bioinformaticians and data scientists working with genomic and multi-omics data
Anyone interested in applying Open Targets data and tools for target prioritization
Speaker: Joseph Pearson, PhD – Global Product Manager, QIAGEN Digital Insights
Learn how OmicSoft’s curated transcriptomic and multi-omics data can be integrated with Open Targets to support large-scale target evaluation. Explore how enterprise scientists can visualize and prioritize therapeutic targets efficiently.
Speaker: Chi Zhang, PhD – Director of Bioinformatics Engineering, Triveni Bio
Discover how PoPS, combined with Locus-to-Gene (L2G) and nearest-gene approaches, improves identification of causal genes for complex traits, with real-world applications in oncology and cardiometabolic research.
Speaker: Jessica Singh – Solutions Consultant, Genomics and Target Discovery, The Hyve
Get the latest on Open Targets developments, including MCPs, AI-driven interpretation, and large language model integration. Jessica will also share upcoming features and collaborations to further enhance target discovery.
The session, moderated by Henk-Jan van den Ham, PhD - Team Lead, Genomics and Target Discovery, The Hyve, will also feature a live Q&A to exchange perspectives across the Open Targets community.